Endo International | ENDP

Endo International Ordinary Shares traded at $0.37 this Friday August 12th, decreasing $0.03 or 6.90 percent since the previous trading session. Looking back, over the last four weeks, Endo International lost 11.41 percent. Over the last 12 months, its price fell by 90.61 percent. Looking ahead, we forecast Endo International Ordinary Shares to be priced at 0.69 by the end of this quarter and at 0.61 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
0.37
Daily Change
-6.90%
Yearly
-90.61%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Takeda 3,798.00 16.00 0.42% 3.38%
AbbVie 142.60 0.52 0.37% 22.42%
Aerie Pharmaceuticals 11.57 0.48 4.33% -21.29%
Amarin 1.65 0.04 2.48% -69.56%
ANI Pharmaceuticals 37.47 2.08 5.88% 24.69%
Bristol-Myers Squibb 75.57 1.11 1.49% 11.94%
Coherus Biosciences 13.76 1.11 8.77% -1.22%
Endo International 0.37 -0.03 -6.90% -90.61%
Hikma Pharmaceutical 1,532.50 -32.50 -2.08% -39.43%
Heron Therapeutics 5.30 0.43 8.83% -52.04%
Horizon Pharma 67.47 0.37 0.55% -36.78%
Jazz Pharmaceuticals 157.08 2.83 1.83% 10.50%
Lannett 0.63 0.05 9.00% -86.09%
Ligand Pharmaceuticals 106.36 4.39 4.31% -0.43%
Eli Lilly 308.08 6.91 2.29% 16.60%
Merck & Co 91.02 2.09 2.35% 18.64%
Novartis 80.10 -0.94 -1.16% -6.82%
Phibro Animal Health 19.20 0.46 2.45% -22.42%
Pacira 57.56 1.30 2.31% -1.30%
Patterson Companies 31.37 0.43 1.39% 5.02%
Pfizer 50.11 1.82 3.77% 3.36%
Perrigo 41.87 0.22 0.53% 2.25%
Revance Therapeutics 22.49 1.05 4.90% -13.57%
Supernus Pharmaceuticals 32.79 1.53 4.89% 32.54%
Teva Pharmaceutical Industries Ltd 3,644.00 8.00 0.22% 12.43%
Xeris Pharmaceuticals Inc 1.87 0.05 2.75% -19.40%
Zoetis 175.67 2.49 1.44% -12.81%

Indexes Price Day Year
US500 4280 72.88 1.73% -4.20%
USND 13047 267.27 2.09% -11.98%
US400 2615 39.33 1.53% -4.26%

Endo International
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.